OTC cough and cold sales value in Great Britain 2024| Statista

The sales value of over-the-counter (OTC) cough, cold and sore throat treatments in Great Britain stood at over 680 million British pounds in 2024. This was the highest value in the provided time interval.

OTC medicine market in Great Britain 

Cough, cold and sore throat medication had the second-highest sales value in 2024, when broken down by OTC drug categories. Pain relief medication was the category with the highest sales value, at approximately 857 million British pounds. Vitamins and minerals had a sales value of 650 million British pounds, the third-highest category overall in Great Britain. Overall, the sales value of OTC drugs has increased from 1.65 billion British pounds in the year 2000 to over four billion British pounds in 2024. 

Growth of other OTC categories

The OTC product category which had the highest growth of sales value in Great Britain from 2023 and 2024 was cough and cold, with a significant growth of nine percent. This was followed by vitamins and minerals, which grew by eight percent compared to the previous year. 

Sales value of OTC cough, cold and sore throat treatments in Great Britain from 2009 to 2024 (in million GBP)

Characteristic	Sales value in million GBP
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

Release date

March 2025

More information

Region

United Kingdom (Great Britain)

Survey time period

2009 to 2024

Supplementary notes

Sales data is for all outlets, excluding health food stores. This statistics was assembled from several PAGB annual highlights. There is no information about previous years' data being restated.

Data for 2016 refers to 52-week period ending April 23, 2016.

Data from 2009 to 2013 taken from annual review's previously published by the source.

Citation formats